• Ownership

Peter A. Thompson - Insider Trading & Ownership

Entity
Individual
Location
C/O Anthera Pharmaceuticals, Inc., 25801 Industrial Boulevard, Suite B, Hayward, CA
Summary
The estimated net worth of Peter A. Thompson is at least $24.8M dollars as of April 4, 2025. Peter A. Thompson is the Director, 10%+ Owner of Corvus Pharmaceuticals, Inc. and owns shares of Corvus Pharmaceuticals, Inc. (CRVS) stock worth about $14.5M. Peter A. Thompson is the Director, 10%+ Owner of Edgewise Therapeutics, Inc. and owns shares of Edgewise Therapeutics, Inc. (EWTX) stock worth about $8.93M. Peter A. Thompson is the Director of Janux Therapeutics, Inc. and owns shares of Janux Therapeutics, Inc. (JANX) stock worth about $1.36M.
All Insider Reports
All Insider Reports

Ownership of Peter A. Thompson

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CRVS Corvus Pharmaceuticals, Inc. Director, 10%+ Owner $14.5M +$2.5M +20.8% Jun 13, 2024
EWTX Edgewise Therapeutics, Inc. Director, 10%+ Owner $8.93M +$10M Apr 3, 2025
JANX Janux Therapeutics, Inc. Director $1.36M Jun 14, 2022
ALPN ALPINE IMMUNE SCIENCES, INC. Director $0 May 18, 2024
SPRY ARS Pharmaceuticals, Inc. Director $0 -$12.6M -100% Aug 26, 2024
DBTX Decibel Therapeutics, Inc. Director, 10%+ Owner Jun 17, 2022
PMVP PMV Pharmaceuticals, Inc. Director, 10%+ Owner Jun 2, 2021
SION Sionna Therapeutics, Inc. Director Feb 10, 2025

Insider Transactions Reported by Peter A. Thompson:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.